Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Numasawa

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Plos One|October 17, 2019
Outcomes of acute coronary syndrome patients with concurrent extra-cardiac vascular disease in the era of transradial coronary intervention: A retrospective multicenter cohort studyMasaki Kodaira, Mitsuaki Sawano, Toshiki Kuno, et al.
The American Journal of Cardiology|April 2, 2023
Ischemic and Bleeding Outcomes in Patients Who Underwent Percutaneous Coronary Intervention With Chronic Kidney Disease or Dialysis (from a Japanese Nationwide Registry)Akihiro Tobe, Mitsuaki Sawano, Shun Kohsaka, et al.
Plos One|August 31, 2013
Impact of coronary dominance on in-hospital outcomes after percutaneous coronary intervention in patients with acute coronary syndromeToshiki Kuno, Yohei Numasawa, Hiroaki Miyata, et al.
Heart and Vessels|February 23, 2013
Anatomical variations affect radial artery spasm and procedural achievement of transradial cardiac catheterizationYohei Numasawa, Akio Kawamura, Shun Kohsaka, et al.
Journal of Cardiology|January 4, 2020
In-hospital outcome in patients presenting with acute coronary syndrome with left main coronary artery disease: A report from Japanese prospective multicenter percutaneous coronary intervention registryHidenori Tani, Mitsuaki Sawano, Yohei Numasawa, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 25, 2020
Transradial Percutaneous Coronary Intervention in Patients With Advanced Chronic Kidney DiseaseFumiaki Yashima, Taku Inohara, Yohei Numasawa, et al.
The Lancet Regional Health. Western Pacific|March 25, 2022
Percutaneous coronary intervention during the COVID-19 pandemic in Japan: Insights from the nationwide registration dataKyohei Yamaji, Shun Kohsaka, Taku Inohara, et al.
Stem Cells (Dayton, Ohio)|July 15, 2011
Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesisYohei Numasawa, Takehiro Kimura, Shunichiro Miyoshi, et al.
Internal Medicine (Tokyo, Japan)|November 21, 2017
Recent Inferior Myocardial Infarction Complicated with a Right Ventricular Thrombus Detected by Three Cardiac Imaging ModalitiesToshiki Kuno, Syohei Imaeda, Kenji Hashimoto, et al.
The American Journal of Cardiology|January 24, 2018
Relation of Baseline Hemoglobin Level to In-Hospital Outcomes in Patients Who Undergo Percutaneous Coronary Intervention (from a Japanese Multicenter Registry)Yohei Numasawa, Ikuko Ueda, Mitsuaki Sawano, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Plos One|October 17, 2019
Outcomes of acute coronary syndrome patients with concurrent extra-cardiac vascular disease in the era of transradial coronary intervention: A retrospective multicenter cohort studyMasaki Kodaira, Mitsuaki Sawano, Toshiki Kuno, et al.
The American Journal of Cardiology|April 2, 2023
Ischemic and Bleeding Outcomes in Patients Who Underwent Percutaneous Coronary Intervention With Chronic Kidney Disease or Dialysis (from a Japanese Nationwide Registry)Akihiro Tobe, Mitsuaki Sawano, Shun Kohsaka, et al.
Plos One|August 31, 2013
Impact of coronary dominance on in-hospital outcomes after percutaneous coronary intervention in patients with acute coronary syndromeToshiki Kuno, Yohei Numasawa, Hiroaki Miyata, et al.
Heart and Vessels|February 23, 2013
Anatomical variations affect radial artery spasm and procedural achievement of transradial cardiac catheterizationYohei Numasawa, Akio Kawamura, Shun Kohsaka, et al.
Journal of Cardiology|January 4, 2020
In-hospital outcome in patients presenting with acute coronary syndrome with left main coronary artery disease: A report from Japanese prospective multicenter percutaneous coronary intervention registryHidenori Tani, Mitsuaki Sawano, Yohei Numasawa, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 25, 2020
Transradial Percutaneous Coronary Intervention in Patients With Advanced Chronic Kidney DiseaseFumiaki Yashima, Taku Inohara, Yohei Numasawa, et al.
The Lancet Regional Health. Western Pacific|March 25, 2022
Percutaneous coronary intervention during the COVID-19 pandemic in Japan: Insights from the nationwide registration dataKyohei Yamaji, Shun Kohsaka, Taku Inohara, et al.
Stem Cells (Dayton, Ohio)|July 15, 2011
Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesisYohei Numasawa, Takehiro Kimura, Shunichiro Miyoshi, et al.
Internal Medicine (Tokyo, Japan)|November 21, 2017
Recent Inferior Myocardial Infarction Complicated with a Right Ventricular Thrombus Detected by Three Cardiac Imaging ModalitiesToshiki Kuno, Syohei Imaeda, Kenji Hashimoto, et al.
The American Journal of Cardiology|January 24, 2018
Relation of Baseline Hemoglobin Level to In-Hospital Outcomes in Patients Who Undergo Percutaneous Coronary Intervention (from a Japanese Multicenter Registry)Yohei Numasawa, Ikuko Ueda, Mitsuaki Sawano, et al.
Pageof 15